Table 1.
Key transcriptional factors of CSCs
| Transcription factor | Cancer type | Effects | Refs |
|---|---|---|---|
| OCT4 | Pancreatic | Chemoresistance, and tumorigenesis | 38-41 |
| SOX2 | Glioma, breast and others | Self-renewal, tumor growth and therapy resistance | 44, 45 |
| KLF4 | Breast, glioma, and osteosarcoma | Metastasis, migration and drug resistance | 50-52 |
| MYC | Glioma, breast | Drug resistance | 54, 55 |
| NANOG | Hepatic, prostate, colorectal, and brain cancers | Tumorigenesis and therapy resistance | 56, 62, 63 |
| Wnt/TCF | Breast and glioma | Metastasis and stemness maintenance | 66, 67 |
| STAT3 | Breast, liver, colon leukemia and prostate | Proliferation, stemness maintenance and immunosuppressive | 69-75 |
| NF-κB | Breast, prostate, ovarian and pancreatic cancer | Pro-inflammatory, angiogenesis and invasion | 76-80 |